CIK 0001658551 · Non-accelerated filer<br>Smaller reporting company
Amylyx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMLX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 464600503
- Phone
- 617-682-0917
- Business address
- 55 CAMBRIDGE PARKWAY, SUITE 6W, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,951,125
- in 9 filings, $8.0M under 10b5-1 plans
Net −$10,951,125. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Cohen Joshua B −$4.0M Co-Chief Executive Officer sold 4% of stake
- Klee Justin B. −$4.0M Co-Chief Executive Officer sold 4% of stake
- FRATES JAMES M −$1.6M Chief Financial Officer sold 18% of stake
- MILNE GEORGE M JR −$831K Director sold 4% of stake
- Bedrosian Camille L −$325K Chief Medical Officer sold 3% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-06 | Mazzariello Gina Chief Legal Officer | Grant or award · Stock Option (right to buy) | +95,777 | 95,777 | ||
| 2025-03-06 | Bedrosian Camille L Chief Medical Officer | Grant or award | +68,420 | 206,800 | ||
| 2025-03-06 | Bedrosian Camille L Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +102,630 | 102,630 | ||
| 2025-03-06 | Klee Justin B. Co-Chief Executive Officer | Grant or award | +180,118 | 3,376,766 | ||
| 2025-03-06 | Klee Justin B. Co-Chief Executive Officer | Grant or award · Stock Option (right to buy) | +270,177 | 270,177 | ||
| 2025-03-06 | Cohen Joshua B Co-Chief Executive Officer | Grant or award | +180,118 | 3,376,770 | ||
| 2025-03-06 | Cohen Joshua B Co-Chief Executive Officer | Grant or award · Stock Option (Right to Buy) | +270,177 | 270,177 | ||
| 2025-03-06 | FRATES JAMES M Chief Financial Officer | Grant or award | +68,420 | 301,884 | ||
| 2025-03-06 | FRATES JAMES M Chief Financial Officer | Grant or award · Stock Option (right to buy) | +102,630 | 102,630 | ||
| 2025-03-03 | Klee Justin B. Co-Chief Executive Officer | Sale | −4,595 | $3.15 | $14K | 3,196,648 |
| 2025-03-03 | Cohen Joshua B Co-Chief Executive Officer | Sale | −4,595 | $3.17 | $15K | 3,196,652 |
| 2025-03-03 | Mazzariello Gina Chief Legal Officer | Sale | −1,611 | $3.12 | $5K | 133,310 |
| 2025-02-24 | Mazzariello Gina Chief Legal Officer | Sale | −4,169 | $3.15 | $13K | 134,921 |
| 2025-02-05 | Klee Justin B. Co-Chief Executive Officer | Option exercise | +36,310 | $1.57 | $57K | 3,201,243 |
| 2025-02-05 | Klee Justin B. Co-Chief Executive Officer | Option exercise · Stock Option (right to buy) | −36,310 | 0 | ||
| 2025-02-03 | Mazzariello Gina Chief Legal Officer | Sale | −3,678 | $3.49 | $13K | 139,090 |
| 2025-02-03 | Cohen Joshua B Co-Chief Executive Officer | Sale | −11,851 | $3.47 | $41K | 3,201,247 |
| 2025-02-03 | Klee Justin B. Co-Chief Executive Officer | Sale | −11,855 | $3.47 | $41K | 3,164,933 |
| 2025-01-24 | MILNE GEORGE M JR Director | Gift | −27,910 | 830,661 | ||
| 2025-01-06 | Klee Justin B. Co-Chief Executive Officer | Sale | −7,471 | $4.04 | $30K | 3,176,788 |
Page 6 of 19 · 362 trades